Pfizer, Flynn face revived U.K. antitrust accusations of ‘unfairly high’ prices on epilepsy drugnews2021-08-05T11:25:06+00:00August 5th, 2021|Fierce Pharma|
Finn Partners boosts health practice with 2 former Ogilvy execs in new senior roles news2021-08-05T02:13:37+00:00August 5th, 2021|Fierce Pharma|
Horizon debuts animated film with Ruby the crystal hunter to help explain cystinosis to young patientsnews2021-08-04T22:39:49+00:00August 4th, 2021|Fierce Pharma|
Feds throw lifeline to shuttered Viatris plant in West Virginia, but its fate remains uncertainnews2021-08-04T21:07:36+00:00August 4th, 2021|Fierce Pharma|
How’s Amgen’s key KRAS launch looking? It’s too early for meaningful sales, but expectations are riding highnews2021-08-04T19:37:55+00:00August 4th, 2021|Fierce Pharma|
Ardelyx slashes one-third of its workforce after FDA rejection for key kidney disease prospectnews2021-08-04T17:21:15+00:00August 4th, 2021|Fierce Pharma|
Demand for Novo Nordisk’s new weight-loss drug Wegovy outstripped early supply, analysts saynews2021-08-04T15:52:51+00:00August 4th, 2021|Fierce Pharma|
With supply problems solved, Novavax inks deal to supply Europe with up to 200M COVID-19 vaccinesnews2021-08-04T15:32:01+00:00August 4th, 2021|Fierce Pharma|
With Delta variant surging, FDA hustles to grant Pfizer’s COVID-19 vaccine a full approval: reportsnews2021-08-04T13:48:40+00:00August 4th, 2021|Fierce Pharma|
Despite FDA holdups, Incyte’s still counting on timely Jakafi, ruxolitinib cream verdictsnews2021-08-04T13:42:07+00:00August 4th, 2021|Fierce Pharma|
